A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival
Sant P. Chawla,
Brian A. Van Tine,
Seth M. Pollack,
Kristen N. Ganjoo,
Anthony Elias,
Richard F. Riedel,
Steven Attia,
Edwin Choy,
Scott H. Okuno,
Mark Agulnik,
Annals of Oncology · 2017 · 13 citations · 0 references